Variant report

Variant	esv34952
Chromosome Location	chr12:48672333-48703533
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:432)
CpG islands
(count:306)
Chromatin interactive
region (count:34)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:432 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:48690330-48690598	K562	blood:	n/a	n/a
2	ARID3A	chr12:48697810-48697842	K562	blood:	n/a	n/a
3	ATF1	chr12:48675696-48675870	K562	blood:	n/a	n/a
4	ATF1	chr12:48690322-48690656	K562	blood:	n/a	n/a
5	BACH1	chr12:48690123-48690696	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr12:48690232-48690618	K562	blood:	n/a	n/a
7	BHLHE40	chr12:48690282-48690694	K562	blood:	n/a	n/a
8	CBX3	chr12:48690262-48690833	K562	blood:	n/a	n/a
9	CCNT2	chr12:48690467-48690661	K562	blood:	n/a	n/a
10	CEBPB	chr12:48691677-48691895	K562	blood:	n/a	n/a
11	CEBPB	chr12:48693069-48693135	K562	blood:	n/a	n/a
12	CEBPB	chr12:48672987-48673226	MCF-7	breast:	n/a	n/a
13	CEBPB	chr12:48685953-48686039	A549	lung:	n/a	n/a
14	CEBPB	chr12:48685858-48686172	K562	blood:	n/a	n/a
15	CEBPB	chr12:48676827-48676839	Hela-S3	cervix:	n/a	n/a
16	CHD2	chr12:48690402-48690644	K562	blood:	n/a	n/a
17	CREB1	chr12:48690377-48690682	A549	lung:	n/a	n/a
18	CTCF	chr12:48680560-48680710	BE2_C	brain:	n/a	chr12:48680655-48680668
19	CTCF	chr12:48680520-48680670	BJ	skin:	n/a	chr12:48680655-48680668
20	CTCF	chr12:48690360-48690510	HPAF	blood vessel:	n/a	n/a
21	CTCF	chr12:48690440-48690590	HCFaa	heart:	n/a	n/a
22	CTCF	chr12:48680620-48680770	HAc	cerebellar:	n/a	chr12:48680655-48680668
23	CTCF	chr12:48680620-48680770	HRE	kidney:	n/a	chr12:48680655-48680668
24	CTCF	chr12:48680541-48680741	Spleen_OC	spleen:	n/a	chr12:48680655-48680668
25	CTCF	chr12:48690680-48690830	GM12871	blood:	n/a	chr12:48690785-48690798
26	CTCF	chr12:48680557-48680768	A549	lung:	n/a	chr12:48680655-48680668
27	CTCF	chr12:48680299-48681298	A549	lung:	n/a	chr12:48680655-48680668
28	CTCF	chr12:48680577-48680722	Fibrobl	skin:	n/a	chr12:48680655-48680668
29	CTCF	chr12:48680540-48680690	MCF-7	breast:	n/a	chr12:48680655-48680668
30	CTCF	chr12:48690420-48690570	AG04449	skin:	n/a	n/a
31	CTCF	chr12:48680580-48680730	NHEK	skin:	n/a	chr12:48680655-48680668
32	CTCF	chr12:48680599-48680672	H1-hESC	embryonic stem cell:	n/a	chr12:48680655-48680668
33	CTCF	chr12:48680580-48680730	AG09309	skin:	n/a	chr12:48680655-48680668
34	CTCF	chr12:48680540-48680690	HCM	heart:	n/a	chr12:48680655-48680668
35	CTCF	chr12:48690360-48690510	HAc	cerebellar:	n/a	n/a
36	CTCF	chr12:48680552-48680758	MCF-7	breast:	n/a	chr12:48680655-48680668
37	CTCF	chr12:48680581-48680737	Gliobla	brain:	n/a	chr12:48680655-48680668
38	CTCF	chr12:48680583-48680749	Hela-S3	cervix:	n/a	chr12:48680655-48680668
39	CTCF	chr12:48680580-48680730	GM12869	blood:	n/a	chr12:48680655-48680668
40	CTCF	chr12:48680620-48680770	HCFaa	heart:	n/a	chr12:48680655-48680668
41	CTCF	chr12:48680542-48680722	K562	blood:	n/a	chr12:48680655-48680668
42	CTCF	chr12:48680524-48680756	Pancreas_OC	pancreas:	n/a	chr12:48680655-48680668
43	CTCF	chr12:48680421-48680789	HepG2	liver:	n/a	chr12:48680655-48680668
44	CTCF	chr12:48680600-48680750	GM12875	blood:	n/a	chr12:48680655-48680668
45	CTCF	chr12:48680540-48680690	SK-N-SH_RA	brain:	n/a	chr12:48680655-48680668
46	CTCF	chr12:48680240-48680390	GM12873	blood:	n/a	n/a
47	CTCF	chr12:48680660-48680810	HFF-Myc	foreskin:	n/a	n/a
48	CTCF	chr12:48680620-48680770	AG04450	lung:	n/a	chr12:48680655-48680668
49	CTCF	chr12:48680571-48680739	GM10266	blood:	n/a	chr12:48680655-48680668
50	CTCF	chr12:48680580-48680730	Caco-2	colon:	n/a	chr12:48680655-48680668

(count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:48690974-48691024	ProgFib	skin:	n/a
2	chr12:48690974-48691024	ProgFib	skin:	n/a
3	chr12:48691036-48691086	CMK	blood:	n/a
4	chr12:48690546-48690596	AG04449	skin:	fetal
5	chr12:48690546-48690596	A549	lung:	n/a
6	chr12:48691036-48691086	ProgFib	skin:	n/a
7	chr12:48690689-48690739	Hepatocyte	liver:	n/a
8	chr12:48690974-48691024	HRCEpiC	kidney:	n/a
9	chr12:48690915-48690965	IMR90	lung:	fetal
10	chr12:48690546-48690596	HRE	kidney:	n/a
11	chr12:48690546-48690596	HNPCEpiC	eye:	n/a
12	chr12:48690546-48690596	Hepatocyte	liver:	n/a
13	chr12:48690546-48690596	SK-N-SH	brain:	n/a
14	chr12:48690689-48690739	NH-A	brain:	n/a
15	chr12:48691036-48691086	IMR90	lung:	fetal
16	chr12:48690546-48690596	ovcar-3	ovarian:	n/a
17	chr12:48690915-48690965	HUVEC	blood vessel:	n/a
18	chr12:48690974-48691024	A549	lung:	n/a
19	chr12:48691036-48691086	HRPEpiC	eye:	n/a
20	chr12:48690689-48690739	ProgFib	skin:	n/a
21	chr12:48690689-48690739	AoSMC	blood vessel:	n/a
22	chr12:48690974-48691024	AG09309	skin:	n/a
23	chr12:48690915-48690965	GM06990	blood:	n/a
24	chr12:48690915-48690965	PrEC	prostate:	n/a
25	chr12:48690974-48691024	Caco-2	colon:	n/a
26	chr12:48691036-48691086	Hela-S3	cervix:	n/a
27	chr12:48690974-48691024	Hepatocyte	liver:	n/a
28	chr12:48690689-48690739	BJ	skin:	n/a
29	chr12:48691036-48691086	SKMC	muscle:	n/a
30	chr12:48690974-48691024	SK-N-SH_RA	brain:	n/a
31	chr12:48690974-48691024	K562	blood:	n/a
32	chr12:48690546-48690596	NB4	blood:	n/a
33	chr12:48690974-48691024	HEK293	kidney:	embryo
34	chr12:48690974-48691024	IMR90	lung:	fetal
35	chr12:48691036-48691086	GM12891	blood:	n/a
36	chr12:48690546-48690596	PrEC	prostate:	n/a
37	chr12:48690546-48690596	SK-N-MC	brain:	n/a
38	chr12:48690689-48690739	U87	brain:	n/a
39	chr12:48690689-48690739	AG09319	gingival:	n/a
40	chr12:48690546-48690596	NHBE	bronchial:	n/a
41	chr12:48690689-48690739	NHDF-neo	bronchial:	n/a
42	chr12:48690546-48690596	HEEpiC	esophagus:	n/a
43	chr12:48690546-48690596	IMR90	lung:	fetal
44	chr12:48690689-48690739	MCF10A-Er-Src	breast:	n/a
45	chr12:48690915-48690965	SAEC	small airway:	n/a
46	chr12:48690546-48690596	HAEpiC	amniotic membrane:	n/a
47	chr12:48690974-48691024	HAEpiC	amniotic membrane:	n/a
48	chr12:48690974-48691024	Jurkat	blood:	n/a
49	chr12:48690974-48691024	BE2_C	brain:	n/a
50	chr12:48691036-48691086	Caco-2	colon:	n/a

(count:34 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:48591795..48593507-chr12:48675174..48677324,2	MCF-7	breast:
2	chr12:48688262..48692290-chr12:48702214..48707293,5	K562	blood:
3	chr12:48680562..48682797-chr12:48688715..48691085,2	MCF-7	breast:
4	chr12:48680075..48681891-chr12:48683513..48685275,2	MCF-7	breast:
5	chr12:48679787..48682010-chr12:48684412..48686927,2	K562	blood:
6	chr12:48677853..48680154-chr12:48686621..48688237,2	MCF-7	breast:
7	chr12:48689650..48692193-chr12:48742789..48745705,2	K562	blood:
8	chr12:48691044..48692701-chr12:48738524..48740208,2	K562	blood:
9	chr12:48672914..48675660-chr12:48743386..48744979,2	MCF-7	breast:
10	chr12:48682061..48686479-chr12:48688143..48691883,6	K562	blood:
11	chr12:48698712..48702509-chr12:48702715..48705745,3	MCF-7	breast:
12	chr12:48683741..48686479-chr12:48688143..48689675,2	K562	blood:
13	chr12:48683741..48686479-chr12:48688143..48689675,2	K562	blood:
14	chr12:48689964..48692021-chr12:48694764..48697453,3	MCF-7	breast:
15	chr12:48690658..48693372-chr12:48744473..48746338,2	K562	blood:
16	chr12:48682061..48686479-chr12:48688143..48691883,6	K562	blood:
17	chr12:48702764..48705017-chr12:48706552..48708449,2	K562	blood:
18	chr12:48680075..48681891-chr12:48683513..48685275,2	MCF-7	breast:
19	chr12:48698712..48702509-chr12:48702715..48705745,3	MCF-7	breast:
20	chr12:48653420..48656308-chr12:48672282..48674655,2	K562	blood:
21	chr12:48678386..48682435-chr12:48742177..48744865,4	MCF-7	breast:
22	chr12:48699980..48703428-chr12:48704506..48706488,3	K562	blood:
23	chr12:48691251..48692971-chr12:48699862..48702712,2	MCF-7	breast:
24	chr12:48680248..48681138-chr12:48730039..48730595,2	MCF-7	breast:
25	chr12:48695552..48697163-chr12:48743180..48744695,2	K562	blood:
26	chr12:48593487..48595723-chr12:48689162..48691231,3	K562	blood:
27	chr12:48688262..48692290-chr12:48702214..48707293,5	K562	blood:
28	chr12:48680562..48682797-chr12:48688715..48691085,2	MCF-7	breast:
29	chr12:48689964..48692021-chr12:48694764..48697453,3	MCF-7	breast:
30	chr12:48679787..48682010-chr12:48684412..48686927,2	K562	blood:
31	chr12:48695827..48697706-chr12:48743436..48745025,2	K562	blood:
32	chr12:48700091..48702915-chr12:48742245..48744697,2	MCF-7	breast:
33	chr12:48699980..48702958-chr12:48704506..48706166,2	K562	blood:
34	chr12:48691251..48692971-chr12:48699862..48702712,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000258234	TF binding region
ENSG00000258234	CpG island
ENSG00000167528	chromatin interactions
ENSG00000269514	chromatin interactions
ENSG00000257735	chromatin interactions
ENSG00000258234	chromatin interactions

Extended variants
information (count: 949 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:949 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs549720275	chr12:48672341-48672342	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs528228072	chr12:48672342-48672343	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs118099575	chr12:48672351-48672352	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs529339481	chr12:48672369-48672370	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs548412407	chr12:48672397-48672398	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs568140071	chr12:48672402-48672403	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs534132217	chr12:48672458-48672459	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs547392628	chr12:48672480-48672481	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs570712171	chr12:48672500-48672501	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs148252583	chr12:48672544-48672545	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs141239843	chr12:48672562-48672563	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs576251473	chr12:48672563-48672564	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs568304272	chr12:48672565-48672566	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs377661926	chr12:48672591-48672592	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs540035126	chr12:48672608-48672609	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs34913635	chr12:48672654-48672655	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
17	rs192826146	chr12:48672667-48672668	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs372042679	chr12:48672681-48672682	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs76180012	chr12:48672719-48672720	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs141696925	chr12:48672739-48672740	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs201170239	chr12:48672741-48672742	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs185708138	chr12:48672755-48672756	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs543454585	chr12:48672828-48672829	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs140028817	chr12:48672887-48672888	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs529374220	chr12:48672942-48672943	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs549194373	chr12:48672995-48672996	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs559765119	chr12:48673012-48673013	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs73308837	chr12:48673016-48673017	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs189648922	chr12:48673045-48673046	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs73308839	chr12:48673104-48673105	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs370512162	chr12:48673109-48673110	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs34524121	chr12:48673129-48673130	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs2732443	chr12:48673134-48673135	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
34	rs143908753	chr12:48673153-48673154	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs181906839	chr12:48673163-48673164	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs572062333	chr12:48673188-48673189	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs534917014	chr12:48673193-48673194	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs147247651	chr12:48673195-48673196	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs578028798	chr12:48673199-48673200	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs543687000	chr12:48673227-48673228	Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs140662845	chr12:48673241-48673242	Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs57911822	chr12:48673262-48673263	Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs542981333	chr12:48673392-48673393	Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs566423531	chr12:48673418-48673419	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs367603026	chr12:48673420-48673421	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs572894349	chr12:48673470-48673471	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs183920916	chr12:48673532-48673533	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs149856917	chr12:48673537-48673538	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs188203536	chr12:48673574-48673575	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs373901318	chr12:48673617-48673618	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:70)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Seminomas	18059402	CNVD
Wilms tumour	21544195	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Neurodevelopmental disorder	22521361	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Hirschsprung''s Disease	21712996	CNVD
Lissencephaly	21572526	CNVD
Lung cancer	18438408	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Breast cancer	19602461	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16272173	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	18632612	CNVD
Follicular lymphoma	20505157	CNVD
Hepatocellular carcinoma	16750200	CNVD
Melanoma	18172304	CNVD
Metanephric adenoma	20802469	CNVD
Glioblastoma multiforme	17387387	CNVD
liposarcomas	17372913	CNVD
Non-small cell lung cancer	24170126	CNVD
Cancer	16751803	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	16616336	CNVD
Intracranial aneurysm	16715129	CNVD
Breast cancer	17661082	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	21785460	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Intracranial ependymoma	16609018	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:370 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:48669600-48675600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr12:48672000-48681000	Enhancers	Primary monocytes fromperipheralblood	blood
3	chr12:48672200-48672400	Enhancers	Primary neutrophils fromperipheralblood	blood
4	chr12:48672200-48672800	Enhancers	Monocytes-CD14+_RO01746	blood
5	chr12:48672400-48672600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
6	chr12:48672400-48673800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
7	chr12:48672400-48674800	Enhancers	Placenta Amnion	Placenta Amnion
8	chr12:48672600-48674000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
9	chr12:48672800-48673000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
10	chr12:48672800-48673000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
11	chr12:48672800-48673000	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
12	chr12:48672800-48673200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
13	chr12:48672800-48674200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
14	chr12:48673000-48673200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
15	chr12:48673000-48673200	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
16	chr12:48673000-48673200	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
17	chr12:48673000-48673200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr12:48673000-48674000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
19	chr12:48673000-48674400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
20	chr12:48673200-48673400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
21	chr12:48673200-48674000	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
22	chr12:48673200-48674000	Enhancers	Monocytes-CD14+_RO01746	blood
23	chr12:48673200-48674200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
24	chr12:48673200-48674600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
25	chr12:48673400-48674000	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
26	chr12:48673400-48674200	Enhancers	Brain Hippocampus Middle	brain
27	chr12:48673400-48676200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
28	chr12:48673600-48673800	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
29	chr12:48673600-48673800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr12:48673800-48675000	Enhancers	Primary neutrophils fromperipheralblood	blood
31	chr12:48674000-48674200	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
32	chr12:48674000-48674200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
33	chr12:48674000-48674600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
34	chr12:48674200-48674800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
35	chr12:48674200-48680200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
36	chr12:48674400-48674800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
37	chr12:48674600-48681000	Enhancers	Monocytes-CD14+_RO01746	blood
38	chr12:48674800-48675800	Weak transcription	Placenta Amnion	Placenta Amnion
39	chr12:48675000-48675400	Weak transcription	Primary neutrophils fromperipheralblood	blood
40	chr12:48675400-48676200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr12:48675400-48676400	Enhancers	Hela-S3	cervix
42	chr12:48675400-48676800	Enhancers	Primary neutrophils fromperipheralblood	blood
43	chr12:48675600-48675800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
44	chr12:48675600-48676200	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
45	chr12:48675600-48676400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
46	chr12:48675800-48676200	Enhancers	Placenta Amnion	Placenta Amnion
47	chr12:48676000-48676200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
48	chr12:48676000-48676200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
49	chr12:48676000-48676400	Bivalent Enhancer	Primary B cells from cord blood	blood
50	chr12:48676400-48676800	Enhancers	Primary B cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links